Chargement en cours…
Novel Technologies for Vaccine Development
This book presents a detailed overview of the development of new viral vector-based vaccines before discussing two major applications: preventive vaccines for infectious diseases and therapeutic cancer vaccines. Viral vector-based vaccines hold a great potential for development into successful pharm...
| Cote: | Libro Electrónico |
|---|---|
| Collectivité auteur: | |
| Autres auteurs: | , |
| Format: | Électronique eBook |
| Langue: | Inglés |
| Publié: |
Vienna :
Springer Vienna : Imprint: Springer,
2014.
|
| Édition: | 1st ed. 2014. |
| Sujets: | |
| Accès en ligne: | Texto Completo |
Table des matières:
- Reverse Genetics Approaches for Rational Design of Inactivated and Live-Attenuated Influenza Vaccines
- Viral-Vectored Vaccines to Control Pathogenic Filoviruses
- Alphavirus Replicon Vectors for Prophylactic Applications and Cancer Intervention
- Current Status and Future of Polio Vaccines and Vaccination
- Current Status of Hantavirus Vaccines Development
- Experimental DNA-Launched Live Attenuated Vaccines against Infections Caused by Flavi- and Alphaviruses
- Sugar-Based Immune Adjuvants for Use in Recombinant, Viral, Vector, DNA and Other Styles of Vaccines
- Adenovirus-based Vectors for the Development of Prophylactic and Therapeutic Vaccines
- Radiovirotherapy for the Treatment of Cancer
- TRICOM Poxviral-Based Vaccines for the Treatment of Cancer
- The Use of Oncolytic Herpesvirus for the Treatment of Cancer
- SA-4-1BBL; A Novel form of the 4-1BB Costimulatory Ligand as an Adjuvant Platform for the Development of Subunit Cancer Vaccines.